Integrated Biopharma, Inc. INBP
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 4.47M | 5.83M | 5.31M | 4.73M | 3.62M |
| Total Receivables | 3.33M | 3.66M | 3.59M | 3.98M | 5.43M |
| Inventory | 9.14M | 8.12M | 8.36M | 10.47M | 9.36M |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 432.00K | 374.00K | 550.00K | 440.00K | 356.00K |
| Total Current Assets | 17.38M | 17.97M | 17.82M | 19.62M | 18.76M |
|
|
|||||
| Total Current Assets | 17.38M | 17.97M | 17.82M | 19.62M | 18.76M |
| Net Property, Plant & Equipment | 4.83M | 5.05M | 2.29M | 2.60M | 2.75M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 3.13M | 3.64M | 3.44M | 3.32M | 3.39M |
| Total Assets | 25.34M | 26.67M | 23.55M | 25.54M | 24.90M |
|
|
|||||
| Total Accounts Payable | 3.20M | 2.97M | 2.14M | 2.80M | 2.27M |
| Total Accrued Expenses | 1.39M | 1.38M | 1.13M | 1.49M | 1.30M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.21M | 1.19M | 267.00K | 474.00K | 679.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 5.80M | 5.53M | 3.54M | 4.76M | 4.25M |
|
|
|||||
| Total Current Liabilities | 5.80M | 5.53M | 3.54M | 4.76M | 4.25M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 1.87M | 2.16M | 237.00K | 287.00K | 336.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 7.67M | 7.69M | 3.78M | 5.05M | 4.58M |
|
|
|||||
| Common Stock & APIC | 52.03M | 51.98M | 51.93M | 51.88M | 51.84M |
| Retained Earnings | -34.26M | -32.90M | -32.06M | -31.30M | -31.42M |
| Treasury Stock & Other | -99.00K | -99.00K | -98.00K | -99.00K | -99.00K |
| Total Common Equity | 17.67M | 18.98M | 19.77M | 20.49M | 20.32M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 17.67M | 18.98M | 19.77M | 20.49M | 20.32M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 17.67M | 18.98M | 19.77M | 20.49M | 20.32M |
|
|
|||||